Cipla stock gains; US FDA inspection concludes with zero observations

Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *